117 related articles for article (PubMed ID: 38857662)
1. Porous PLGA microparticles prepared with nanosized/micronized sugar particles as porogens.
Zhang C; Bodmeier R
Int J Pharm; 2024 Jun; 660():124329. PubMed ID: 38857662
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of PLGA microparticle properties loaded with micronized, nanosized or dissolved drug.
Zhang C; Bodmeier R
Int J Pharm; 2022 Nov; 628():122313. PubMed ID: 36272513
[TBL] [Abstract][Full Text] [Related]
3. Direct drug milling in organic PLGA solution facilitates the encapsulation of nanosized drug into PLGA microparticles.
Zhang C; Bodmeier R
Eur J Pharm Biopharm; 2023 Oct; 191():1-11. PubMed ID: 37579890
[TBL] [Abstract][Full Text] [Related]
4. Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles.
Jaraswekin S; Prakongpan S; Bodmeier R
J Microencapsul; 2007 Mar; 24(2):117-28. PubMed ID: 17454423
[TBL] [Abstract][Full Text] [Related]
5. Efficient and prolonged antibacterial activity from porous PLGA microparticles and their application in food preservation.
Biswal AK; P H; Saha S
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110496. PubMed ID: 31923956
[TBL] [Abstract][Full Text] [Related]
6. Preparation of large porous deslorelin-PLGA microparticles with reduced residual solvent and cellular uptake using a supercritical carbon dioxide process.
Koushik K; Kompella UB
Pharm Res; 2004 Mar; 21(3):524-35. PubMed ID: 15070105
[TBL] [Abstract][Full Text] [Related]
7. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
[TBL] [Abstract][Full Text] [Related]
8. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
9. Preparation and In-vitro Evaluation of Controlled Release PLGA Microparticles Containing Triptoreline.
Mahboubian A; Hashemein SK; Moghadam S; Atyabi F; Dinarvand R
Iran J Pharm Res; 2010; 9(4):369-78. PubMed ID: 24381601
[TBL] [Abstract][Full Text] [Related]
10. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method.
Elkharraz K; Ahmed AR; Dashevsky A; Bodmeier R
Int J Pharm; 2011 May; 409(1-2):89-95. PubMed ID: 21356287
[TBL] [Abstract][Full Text] [Related]
11. Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly(lactide-co-glycolide) microparticles.
Luan X; Skupin M; Siepmann J; Bodmeier R
Int J Pharm; 2006 Nov; 324(2):168-75. PubMed ID: 16854540
[TBL] [Abstract][Full Text] [Related]
12. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.
Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V
J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation and release of the hypnotic agent zolpidem from biodegradable polymer microparticles containing hydroxypropyl-beta-cyclodextrin.
Trapani G; Lopedota A; Boghetich G; Latrofa A; Franco M; Sanna E; Liso G
Int J Pharm; 2003 Dec; 268(1-2):47-57. PubMed ID: 14643976
[TBL] [Abstract][Full Text] [Related]
14. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY
J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826
[TBL] [Abstract][Full Text] [Related]
15. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
[TBL] [Abstract][Full Text] [Related]
16. Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.
Intra J; Salem AK
J Drug Target; 2011 Jul; 19(6):393-408. PubMed ID: 20681752
[TBL] [Abstract][Full Text] [Related]
17. NanoCipro encapsulation in monodisperse large porous PLGA microparticles.
Arnold MM; Gorman EM; Schieber LJ; Munson EJ; Berkland C
J Control Release; 2007 Aug; 121(1-2):100-9. PubMed ID: 17604870
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and in vitro release study of BSA-loaded double-walled glucose-poly(lactide-co-glycolide) microspheres.
Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Mohamed F; Doolaanea AA; Kamaruzzaman YB
Arch Pharm Res; 2016 Sep; 39(9):1242-56. PubMed ID: 26818028
[TBL] [Abstract][Full Text] [Related]
19. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
20. Modification of the tri-phasic drug release pattern of leuprolide acetate-loaded poly(lactide-co-glycolide) microparticles.
Luan X; Bodmeier R
Eur J Pharm Biopharm; 2006 Jun; 63(2):205-14. PubMed ID: 16621485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
